4553.T Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 09:15):

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan...

Stats
Dzisiejszy wolumen	94 800.00
Średni wolumen	167 551
Kapitalizacja rynkowa	136.48B
EPS	¥0 ( 2024-02-12 )
Następna data zysków	( ¥38.66 ) 2024-05-12
Last Dividend	¥30.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	11.63
ATR14	¥1.288 (0.05%)

Wolumen Korelacja

Długi: -0.07 (neutral)

Krótki: -0.30 (neutral)

Signal:(59.213) Neutral

Towa Pharmaceutical Co., Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Towa Pharmaceutical Co., Korelacja - Waluta/Towar

-0.03
( neutral )

0.18
( neutral )

-0.04
( neutral )

-0.37
( neutral )

0.32
( neutral )

-0.02
( neutral )

Towa Pharmaceutical Co., Finanse

Annual	2022
Przychody:	¥208.86B
Zysk brutto:	¥72.71B (34.81 %)
EPS:	¥44.72

FY	2022
Przychody:	¥208.86B
Zysk brutto:	¥72.71B (34.81 %)
EPS:	¥44.72

FY	2022
Przychody:	¥165.62B
Zysk brutto:	¥70.19B (42.38 %)
EPS:	¥323.36

FY	2021
Przychody:	¥154.90B
Zysk brutto:	¥65.45B (42.25 %)
EPS:	¥283.62

Financial Reports:

No articles found.

Towa Pharmaceutical Co., Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥30.00 (N/A)	¥0 (N/A)	¥30.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Towa Pharmaceutical Co., Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.24 - good (92.41%) | Divividend Growth Potential Score: 4.05 - Stable (19.05%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥1.667	2005-03-28
Last Dividend	¥30.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	38	--
Total Paid Out	¥541.50	--
Avg. Dividend % Per Year	0.00%	--
Score	3.37	--
Div. Sustainability Score	9.24
Div.Growth Potential Score	4.05
Div. Directional Score	6.64	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.27 %

Dividend Stability

0.10 Bad

Dividend Score

3.37

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
9434.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8086.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7416.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
6632.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
5958.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4659.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
3896.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
3116.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
2002.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9997.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0496	1.500	9.01	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0283	1.200	9.06	10.00	[0 - 0.3]
returnOnEquityTTM	0.0814	1.500	-0.207	-0.310	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.77	0.800	1.148	0.919	[1 - 3]
quickRatioTTM	1.173	0.800	7.81	6.25	[0.8 - 2.5]
cashRatioTTM	0.399	1.500	8.89	10.00	[0.2 - 2]
debtRatioTTM	0.473	-1.500	2.12	-3.17	[0 - 0.6]
interestCoverageTTM	16.44	1.000	5.02	5.02	[3 - 30]
operatingCashFlowPerShareTTM	821.31	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	821.31	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	1.318	-1.500	4.73	-7.09	[0 - 2.5]
grossProfitMarginTTM	0.347	1.000	7.56	7.56	[0.2 - 0.8]
operatingProfitMarginTTM	0.0564	1.000	-0.871	-0.871	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.206	1.000	9.97	9.97	[0.2 - 2]
assetTurnoverTTM	0.571	0.800	9.53	7.62	[0.5 - 2]
Total Score				9.24

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	11.63	1.000	8.93	0	[1 - 100]
returnOnEquityTTM	0.0814	2.50	-0.133	-0.310	[0.1 - 1.5]
freeCashFlowPerShareTTM	821.31	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	2.16	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	821.31	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.135	1.500	-4.23	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.171	1.000	8.23	0	[0.1 - 0.5]
Total Score				4.05

Towa Pharmaceutical Co.,

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.